147 related articles for article (PubMed ID: 31907989)
1. Development of a novel liposomal nanoparticle formulation of cisplatin to breast cancer therapy.
Ghafari M; Haghiralsadat F; Khanamani Falahati-Pour S; Zavar Reza J
J Cell Biochem; 2020 Jul; 121(7):3584-3592. PubMed ID: 31907989
[TBL] [Abstract][Full Text] [Related]
2. PEGylated Liposomes of Meloxicam: Optimization by Quality by Design, in vitro Characterization and Cytotoxicity Evaluation.
Shaji J; Menon I
Pharm Nanotechnol; 2017; 5(2):119-137. PubMed ID: 28462699
[TBL] [Abstract][Full Text] [Related]
3. Paclitaxel and curcumin coadministration in novel cationic PEGylated niosomal formulations exhibit enhanced synergistic antitumor efficacy.
Alemi A; Zavar Reza J; Haghiralsadat F; Zarei Jaliani H; Haghi Karamallah M; Hosseini SA; Haghi Karamallah S
J Nanobiotechnology; 2018 Mar; 16(1):28. PubMed ID: 29571289
[TBL] [Abstract][Full Text] [Related]
4. PEGylated liposomes of anastrozole for long-term treatment of breast cancer: in vitro and in vivo evaluation.
Shavi GV; Sreenivasa Reddy M; Raghavendra R; Nayak UY; Kumar AR; Deshpande PB; Udupa N; Behl G; Dave V; Kushwaha K
J Liposome Res; 2016; 26(1):28-46. PubMed ID: 25853340
[TBL] [Abstract][Full Text] [Related]
5. Preparation, characterization, and cytotoxic effects of liposomal nanoparticles containing cisplatin: an in vitro study.
Poy D; Akbarzadeh A; Ebrahimi Shahmabadi H; Ebrahimifar M; Farhangi A; Farahnak Zarabi M; Akbari A; Saffari Z; Siami F
Chem Biol Drug Des; 2016 Oct; 88(4):568-73. PubMed ID: 27178305
[TBL] [Abstract][Full Text] [Related]
6. The Role of Polyethylene Glycol Size in Chemical Spectra, Cytotoxicity, and Release of PEGylated Nanoliposomal Cisplatin.
Shirzad M; Jamehbozorgi S; Akbarzadeh I; Aghabozorg HR; Amini A
Assay Drug Dev Technol; 2019 Jul; 17(5):231-239. PubMed ID: 31081680
[TBL] [Abstract][Full Text] [Related]
7. Enhanced Efficacy of PEGylated Liposomal Cisplatin: In Vitro and In Vivo Evaluation.
Ghaferi M; Asadollahzadeh MJ; Akbarzadeh A; Ebrahimi Shahmabadi H; Alavi SE
Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31952316
[TBL] [Abstract][Full Text] [Related]
8. Vitamin E D-alpha-tocopheryl polyethylene glycol 1000 succinate-conjugated liposomal docetaxel reverses multidrug resistance in breast cancer cells.
Li N; Fu T; Fei W; Han T; Gu X; Hou Y; Liu Y; Yang J
J Pharm Pharmacol; 2019 Aug; 71(8):1243-1254. PubMed ID: 31215039
[TBL] [Abstract][Full Text] [Related]
9. Intercalation of curcumin into liposomal chemotherapeutic agent augments apoptosis in breast cancer cells.
Mahmoudi R; Hassandokht F; Ardakani MT; Karimi B; Roustazadeh A; Tarvirdipour S; Barmak MJ; Nikseresht M; Baneshi M; Mousavizadeh A; Shirazi MS; Alipour M; Bardania H
J Biomater Appl; 2021 Mar; 35(8):1005-1018. PubMed ID: 33283585
[TBL] [Abstract][Full Text] [Related]
10. A comprehensive mathematical model of drug release kinetics from nano-liposomes, derived from optimization studies of cationic PEGylated liposomal doxorubicin formulations for drug-gene delivery.
Haghiralsadat F; Amoabediny G; Helder MN; Naderinezhad S; Sheikhha MH; Forouzanfar T; Zandieh-Doulabi B
Artif Cells Nanomed Biotechnol; 2018 Feb; 46(1):169-177. PubMed ID: 28376641
[TBL] [Abstract][Full Text] [Related]
11. Comparison, synthesis and evaluation of anticancer drug-loaded polymeric nanoparticles on breast cancer cell lines.
Eatemadi A; Darabi M; Afraidooni L; Zarghami N; Daraee H; Eskandari L; Mellatyar H; Akbarzadeh A
Artif Cells Nanomed Biotechnol; 2016 May; 44(3):1008-17. PubMed ID: 25707442
[TBL] [Abstract][Full Text] [Related]
12. Anti-cancer activity of pegylated liposomal trans-anethole on breast cancer cell lines MCF-7 and T47D.
Shahbazian S; Akbarzadeh A; Torabi S; Omidi M
Biotechnol Lett; 2015 Jul; 37(7):1355-9. PubMed ID: 25792512
[TBL] [Abstract][Full Text] [Related]
13. Oleanolic acid liposomes with polyethylene glycol modification: promising antitumor drug delivery.
Gao D; Tang S; Tong Q
Int J Nanomedicine; 2012; 7():3517-26. PubMed ID: 22848175
[TBL] [Abstract][Full Text] [Related]
14. RETRACTED: Enhanced antitumor efficacy of 5-fluorouracil loaded methoxy poly(ethylene glycol)-poly(lactide) nanoparticles for efficient therapy against breast cancer.
Yuan Z; Qu X; Wang Y; Zhang DY; Luo JC; Jia N; Zhang ZT
Colloids Surf B Biointerfaces; 2015 Apr; 128():489-497. PubMed ID: 25779606
[TBL] [Abstract][Full Text] [Related]
15. Characterization of cisplatin-loaded chitosan nanoparticles and rituximab-linked surfaces as target-specific injectable nano-formulations for combating cancer.
Sultan MH; Moni SS; Madkhali OA; Bakkari MA; Alshahrani S; Alqahtani SS; Alhakamy NA; Mohan S; Ghazwani M; Bukhary HA; Almoshari Y; Salawi A; Alshamrani M
Sci Rep; 2022 Jan; 12(1):468. PubMed ID: 35013493
[TBL] [Abstract][Full Text] [Related]
16. Surface-modified Epirubicin-HCl liposomes and its in vitro assessment in breast cancer cell-line: MCF-7.
Gandhi R; Khatri N; Baradia D; Vhora I; Misra A
Drug Deliv; 2016 May; 23(4):1152-62. PubMed ID: 25586675
[TBL] [Abstract][Full Text] [Related]
17. Co-loaded paclitaxel/rapamycin liposomes: Development, characterization and in vitro and in vivo evaluation for breast cancer therapy.
Eloy JO; Petrilli R; Topan JF; Antonio HMR; Barcellos JPA; Chesca DL; Serafini LN; Tiezzi DG; Lee RJ; Marchetti JM
Colloids Surf B Biointerfaces; 2016 May; 141():74-82. PubMed ID: 26836480
[TBL] [Abstract][Full Text] [Related]
18. Poly(ethylene glycol)-block-poly(ε-caprolactone)-and phospholipid-based stealth nanoparticles with enhanced therapeutic efficacy on murine breast cancer by improved intracellular drug delivery.
He X; Li L; Su H; Zhou D; Song H; Wang L; Jiang X
Int J Nanomedicine; 2015; 10():1791-804. PubMed ID: 25784805
[TBL] [Abstract][Full Text] [Related]
19. Preparation, characterization and
Zare Kazemabadi F; Heydarinasab A; Akbarzadeh A; Ardjmand M
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3222-3230. PubMed ID: 31373225
[No Abstract] [Full Text] [Related]
20. Development of a Liposomal Formulation of Acetyltanshinone IIA for Breast Cancer Therapy.
Wang Q; Luo M; Wei N; Chang A; Luo KQ
Mol Pharm; 2019 Sep; 16(9):3873-3886. PubMed ID: 31389706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
